Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes.

Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes.

<p>Patients ablated for supraventricular tachycardias—MCS and ablation details and outcomes.</p>

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Milan Dusik (18391630) (author)
مؤلفون آخرون:	Stepan Havranek (2588023) (author), Daniel Rob (3344015) (author), Jan Simek (2588032) (author), Martin Valek (22250603) (author), Zdenka Fingrova (2588014) (author), Tomas Boucek (22250606) (author), Jan Pudil (8822528) (author), Ales Linhart (695297) (author), Jan Belohlavek (695300) (author)
منشور في:	2025
الموضوعات:	Medicine Microbiology Cell Biology Ecology Developmental Biology Marine Biology Science Policy Hematology Infectious Diseases Biological Sciences not elsewhere classified xlink "> short severe cardiogenic shock mechanical circulatory supports focal atrial tachycardia ablate strategy ). 2x impella cp hemodynamically significant arrhythmias 1x va ecmo 1x impella 5 identify cs patients catheter ablation may one patient underwent cs patients treated impella cp va ecmo cs ). one patient 5 ). significant complications refractory arrhythmias catheter ablation atrial fibrillation 5 patients patient died 1 patient three patients stabilize patients seven patients nine patients 6 patients 4 patients 3 patients 2 patients ventricular tachycardias treatment resistant successfully weaned successfully explanted retrospectively analysed january 2020 iqr 67 iqr 60 feasible approach dedicated registry august 2024 arrhythmia recurred analysed separately 8 males 66 %). 56 %). 30 days
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

Cannot write session to /tmp/vufind_sessions/sess_7h8m1h0f8727nlot3onb677seu